The partners aim to improve the ability to predict pancreatic cancer patients' responses to treatment.
In PNAS this week: genome and transcriptome sequencing study of tobacco plants, molecular effects of cytochrome c oxidase mutations, and more.
The researchers analyzed DNA from more than 6,500 samples taken from patients, staff, patient rooms, nurse stations, water, and air.
In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.
In PNAS this week: genetic hints of adaptive evolution in Atlantic herring, ancestry of ancient individuals from the Pacific Northwest, and more.
Using monogenic diabetes registry examples, a University of Chicago researcher argued that appropriate genetic testing is needed to detect monogenic diabetes.
Data generated through the collaboration will be used to predict how breast cancer patients will respond to treatment.
The system, developed in 2007 as an online portal to access hardware and software for automated metagenome analysis, has strained to meet user demand.
The update includes several key initiatives such as a liquid biopsy database, a DoD-led longitudinal study, and NCI cloud collaborations with Amazon and Microsoft.
The newly minted company offers panel, whole-genome and whole exome sequencing, as well as bioinformatics analysis and reporting services to oncologists.
While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.
Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.
In Nature this week: paternal age associated with de novo mutations in children, and more.
Nature News writes that researchers are still wrangling over the role of the p-value.